Product Information
Registration Status: ActivePERGILAS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 70MG/VIAL is approved to be sold in Singapore with effective from 2019-11-18. It is marketed by RANBAXY (MALAYSIA) SDN. BHD., with the registration number of SIN15856P.
This product contains Caspofungin 70mg/vial in the form of INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. It is approved for INTRAVENOUS use.
This product is manufactured by MEFAR İLAÇ SANAYİİ A.Ş.(Primary & Secondary packager) in TURKEY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Description
Caspofungin (brand name Cancidas worldwide) is an antifungal drug, the first of a new class termed the echinocandins from Merck & Co., Inc. It shows activity against infections with Aspergillus and Candida, and works by inhibiting β(1,3)-D-Glucan of the fungal cell wall. Caspofungin is administered intravenously.
Indication
For the treatment of esophageal candidiasis and invasive aspergillosis in patients who are refractory to or intolerant of other therapies.
Mechanism of Action
Caspofungin inhibits the synthesis of beta-(1,3)-D-glucan, an essential component of the cell wall of Aspergillus species and Candida species. beta-(1,3)-D-glucan is not present in mammalian cells. The primary target is beta-(1,3)-glucan synthase.
Pharmacokinetics
- Absorption
- 92% tissue distribution within 36-48 hours after intravenous infusion
- Distribution
- Metabolism
- Metabolized slowly by hydrolysis and N-acetylation
- Elimination
Clearance
* 12 mL/min [After single IV administration]
Toxicity
Side effects include rash, swelling, and nausea (rare)
Active Ingredient/Synonyms
(4R,5S)-5-((2-Aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(P-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide | 1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin b0 | Caspofungin |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.